Early stages of Laryngeal Cancer
Keywords:
CANCER CARE FACILITIES, NEOPLASMS, LARYNGEAL NEOPLASMS /drug therapy, EARLY DIAGNOSIS, SURVIVORSHIP.Abstract
Introduction: laryngeal cancer is diagnosed with the highest incidence at an early stage, it represents the second most common cause of malignant neoplasms of the respiratory tract after lung cancer, its diagnosis and effective treatment to reduce morbidity and mortality is of vital importance.
Objective: to describe the results obtained in the management of patients with laryngeal cancer in early stages.
Methods: a retrospective, descriptive study was conducted at the National Institute of Oncology and Radiobiology, from January 1, 2005 to December 31, 2009. The study population consisted of all patients with early-stage squamous cell carcinoma of the larynx. All clinical history information was collected and the results were recorded on the data collection sheet.
Results: male gender predominance was found in the series studied (86,5 %) and the age group of 60 years (64,5 %) and older. It was found that more than half of the cases had a history of smoking and alcoholism (71,3 %). Dysphonia was the main reason for consultation (96,8 %). The most affected anatomical site was the glottis (87.6 %) and the well-differentiated histological variety predominated with 58,2 %. Stage-I was 61,4 %. 78,5 % of the patients received radiotherapy as the only modality.
Conclusions: the socio-demographic and therapeutic variables of the patients in this series are similar to those reported by other authors. When comparing it with national and international series.
Downloads
References
1. García-Sáncheza M, Romero-Duránb E, Mantilla-Moralesb A, Gallegos-Hernándezb JF. Laringectomía subtotal supracricoidea. La importancia del análisis histopatológico. Gaceta Mexicana de Oncología [Intenet] 2014 [Citado 20/05/2018]; 13(3): [aprox. 5p.]. Disponible en: http://www.medigraphic.com/pdfs/actmed/am-2014/am143c.pdf
Consultado en junio de 2014. www.sinais.salud.gob.mx. 2008.
2. Choong N, Vokes E. Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer. CA Cancer J Clin. [Intenet] 2008 [Citado 20/05/2018]; 58: [aprox. 20p.]. Disponible en: https://onlinelibrary.wiley.com/doi/pdf/10.3322/CA.2007.0004
3. Ram Chang A, Wu HG, Pack CH, Kyung Jeon Y, Kim CW.Expression of Epidermal Growth Factor Receptor and Cyclin D1 in Pretreatment Biopsies as a Predictive Factor of Radiotherapy Efficacy in Early Glottic Cancer. Head & Neck. [Intenet] 2008 [Citado 20/05/2018]; 30 (7): [aprox. 5p.]. Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/hed.20788
4. Jatin S. Cirugía y Oncología de Cabeza y Cuello. 3ra edition; 2004.p. 268-270.
5. Colmenarejo R, Menendez PC, Garcia JL. Cáncer de Laringe. In: Cortés Funes H, Colomer R. Tratado de Oncología. 2da Ed. 2009; 58:169-190.
6. Mendehall WM, Werning JW, Hinerman RW, et al . Management of T1-T2 Glottic Carcinomas. Cancer. [Intenet] 2004 [Citado 20/05/2018]; 100: [aprox. 6p.].Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/cncr.20181
7. Mena Canata C, Osorio M, Amarilla P, González J, Bozano J. Resultados de las laringectomías conservadoras en el carcinoma de laring. An. Fac. Cienc. Méd [Intenet] 2014 [Citado 20/05/2018]; 47(2): [aprox. 18p.]. Disponible en: http://scielo.iics.una.py/pdf/anales/v47n2/v47n2a02.pdf
8. Tobacco smoke and involuntary smoking.IARC Monogr Evol Carcinog Risks Hum [Intenet] 2004 [Citado 20/05/2018]; 83. [aprox. 20p. ]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/15285078
9. Ramos Aguerri A. Manual Práctico de Oncología Radioterápica. Madrid: SEOR; 2013.p.1-429. Disponible en: http://www.seor.es/wp-content/uploads/Manual-Practico-de-Oncolog%C3%ADa-Radioterapica.pdf.
10. Soon-Hyun A, Hyun Jun H, Soon Young K, Kee Hwan K, Jong-Lyel R, Junsun R, et al. Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery. Clinical and Experimental Otorhinolaryngology [Intenet] March 2017 [Citado 20/05/2018]; 10(1): [aprox. 43p.]. Disponible en:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327593/pdf/ceo-2016-01389.pdf
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
